🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10288+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10288 recruiting trials

Phase 1RecruitingNCT07036029

NAL ER IPF Respiratory Function and Safety Study

👨‍⚕️ Chief Development Officer, Trevi Therapeutics📍 2 sites📅 Started Aug 2025View details ↗
Phase 2, PHASE3RecruitingNCT07058077

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 21 sites📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06446245

Adjunctive Doxycycline for Central Nervous System Tuberculosis

🏥 National University Hospital, Singapore📍 5 sites📅 Started Aug 2025View details ↗
RecruitingNCT06958107

LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients

👨‍⚕️ Johann Hsu, MD, Wake Forest University Health Sciences📍 2 sites📅 Started Aug 2025View details ↗
NARecruitingNCT07180901

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer

👨‍⚕️ Houda Bahig, MD PhD, Centre hospitalier de l'Université de Montréal (CHUM)📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06747611

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

👨‍⚕️ Maria K Hordinsky, MD, University of Minnesota📍 1 site📅 Started Aug 2025View details ↗
Phase 3Enrolling by InvitationNCT07219485

A Study of Pitolisant in Participants With Prader-Willi Syndrome

👨‍⚕️ David Seiden, MD, Harmony Biosciences Management, Inc.📍 1 site📅 Started Aug 2025View details ↗
Phase 3RecruitingNCT07188584

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

🏥 Ming-Yuan Chen📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07070700

Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma

🏥 Fudan University📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT07013149

The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension

🏥 University of Sao Paulo General Hospital📍 1 site📅 Started Aug 2025View details ↗
Phase 2Enrolling by InvitationNCT06867107

A Long-term Follow-up Study for Participants That Completed the SAT-3247-CL-101 Study

🏥 Satellos Bioscience, Inc.📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06445166

Propranolol for the Treatment of Kaposi Sarcoma in Adults

👨‍⚕️ Lee Ratner, M.D., Ph.D., Washington University School of Medicine📍 1 site📅 Started Aug 2025View details ↗
Phase 1, PHASE2RecruitingNCT07018752

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

👨‍⚕️ François LEMONNIER, Pr, Hôpital Henri Mondor - Lymphoid Malignancies Unit📍 20 sites📅 Started Aug 2025View details ↗
EARLY_Phase 1RecruitingNCT07029204

Intralesional Cyclosporine for Alopecia Areata

👨‍⚕️ Oma Agbai, MD, UC Davis Health Department of Dermatology📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07039526

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

👨‍⚕️ John Waters, M.D., University of Texas Southwestern Medical Center📍 1 site📅 Started Aug 2025View details ↗
Phase 1RecruitingNCT06479811

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

👨‍⚕️ Frank I Lin, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Aug 2025View details ↗
NARecruitingNCT07478224

An Interventional Study to Evaluate the Impact of Blood Flow Restriction Training on Muscle, Bone, and Quality of Life in Adults With Osteogenesis Imperfecta Type I

👨‍⚕️ Charlotte Verroken, PhD, MD, University Hospital, Ghent📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07065968

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

👨‍⚕️ Xiao-Hui Zhang, MD, Peking University Institute of Hematology, Peking University People's Hospital📍 3 sites📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06776250

Study of How Safe and Effective Tarlatamab is in Brain Cancers

👨‍⚕️ Eric Chen, MD, Princess Margaret Cancer Centre/University Health Network📍 1 site📅 Started Aug 2025View details ↗
Phase 1, PHASE2RecruitingNCT07081646

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

🏥 Alexion Pharmaceuticals, Inc.📍 18 sites📅 Started Aug 2025View details ↗
← PreviousPage 74 of 515Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →